|
DK1104291T3
(da)
|
1998-07-17 |
2006-01-16 |
Janssen Pharmaceutica Nv |
Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
|
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
|
DK1163234T3
(da)
|
1999-03-24 |
2006-02-27 |
Scherer Technologies Inc R P |
Farmaceutiske formuleringer med forbedret vandoplöselighed
|
|
KR100432949B1
(ko)
*
|
2000-06-13 |
2004-05-31 |
코오롱제약주식회사 |
생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
|
|
US6663897B2
(en)
*
|
2001-02-06 |
2003-12-16 |
Dsm Ip Assets B.V. |
Oral itraconazole formulations and methods of making the same
|
|
EP1370543B1
(en)
|
2001-02-14 |
2006-10-25 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
|
|
EP1397367A2
(en)
|
2001-04-09 |
2004-03-17 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
|
|
US7622490B2
(en)
|
2001-05-11 |
2009-11-24 |
Tibotec Pharmaceuticals, Ltd. |
Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
|
|
WO2002100407A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Smartrix Technologies Inc. |
Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
|
|
US8071133B2
(en)
|
2001-08-20 |
2011-12-06 |
Stiefel Laboratories, Inc. |
Oral dosage forms of water insoluble drugs and methods of making the same
|
|
US7763641B2
(en)
|
2001-12-21 |
2010-07-27 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
|
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
|
CA2485903C
(en)
|
2002-05-17 |
2011-08-16 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
|
|
NZ538714A
(en)
|
2002-08-14 |
2007-03-30 |
Tibotec Pharm Ltd |
Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
|
|
KR100557680B1
(ko)
*
|
2002-11-23 |
2006-03-07 |
한국유나이티드제약 주식회사 |
이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
|
|
DK1438960T4
(da)
*
|
2003-01-14 |
2013-03-25 |
Cimex Pharma Ag |
Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
|
|
DK1438961T4
(da)
*
|
2003-01-14 |
2014-11-17 |
Acino Pharma Ag |
Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
|
|
EP1651192A1
(en)
|
2003-08-06 |
2006-05-03 |
Nirmal Mulye |
Pharmaceutical composition containing water soluble drug
|
|
CA2531766C
(en)
|
2003-09-11 |
2012-11-27 |
Tibotec Pharmaceuticals Ltd. |
Entry inhibitors of the hiv virus
|
|
EP1568369A1
(en)
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of meloxicam for the treatment of respiratory diseases in pigs
|
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
|
AU2005244121B2
(en)
|
2004-05-07 |
2012-01-19 |
Sequoia Pharmaceuticals, Inc. |
Resistance-repellent retroviral protease inhibitors
|
|
MXPA06013315A
(es)
|
2004-05-17 |
2007-02-02 |
Tibotec Pharm Ltd |
1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
|
|
TW200607502A
(en)
|
2004-05-17 |
2006-03-01 |
Tibotec Pharm Ltd |
6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
|
|
KR20070015608A
(ko)
|
2004-05-17 |
2007-02-05 |
티보텍 파마슈티칼즈 리미티드 |
1-헤테로사이클일-1,5-디히드로-피리도[3,2-b]인돌-2-온
|
|
RU2008143342A
(ru)
|
2006-04-03 |
2010-05-10 |
Тиботек Фармасьютикалз Лтд. (Ie) |
3, 4-дигидроимидазо(4, 5-b)пиридин-5-оны, ингибирующие вич(hiv)
|
|
KR20090065524A
(ko)
*
|
2006-09-04 |
2009-06-22 |
파나세아 바이오테크 리미티드 |
프로그래머블 부력전달기술
|
|
KR100809903B1
(ko)
*
|
2006-09-05 |
2008-03-06 |
주식회사유한양행 |
안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
|
|
CN101283984B
(zh)
*
|
2007-04-12 |
2010-05-26 |
永胜药品工业股份有限公司 |
高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
|
|
JP2008280254A
(ja)
*
|
2007-05-08 |
2008-11-20 |
Everest Pharm Industrial Co Ltd |
生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
|
|
US8313527B2
(en)
|
2007-11-05 |
2012-11-20 |
Allergan, Inc. |
Soft prosthesis shell texturing method
|
|
JP5745855B2
(ja)
|
2007-11-28 |
2015-07-08 |
セコイア、ファーマシューティカルズ、インコーポレイテッドSequoia Pharmaceuticals,Inc. |
シトクロムp450 2d6を阻害するための組成物および方法
|
|
CA2716348C
(en)
|
2008-02-21 |
2017-04-04 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome p450
|
|
US9050184B2
(en)
|
2008-08-13 |
2015-06-09 |
Allergan, Inc. |
Dual plane breast implant
|
|
US8877822B2
(en)
|
2010-09-28 |
2014-11-04 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US9138309B2
(en)
|
2010-02-05 |
2015-09-22 |
Allergan, Inc. |
Porous materials, methods of making and uses
|
|
US9205577B2
(en)
|
2010-02-05 |
2015-12-08 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
GB2479213B
(en)
|
2010-04-01 |
2013-07-10 |
Theravida Inc |
Pharmaceutical formulations for the treatment of overactive bladder
|
|
CN102971018B
(zh)
*
|
2010-05-11 |
2016-02-03 |
阿勒根公司 |
致孔剂组合物、制备方法及用途
|
|
US11202853B2
(en)
|
2010-05-11 |
2021-12-21 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US8679279B2
(en)
|
2010-11-16 |
2014-03-25 |
Allergan, Inc. |
Methods for creating foam-like texture
|
|
CN102100678B
(zh)
*
|
2011-02-18 |
2012-10-17 |
天津力生制药股份有限公司 |
伊曲康唑硫酸盐微丸及其制备方法
|
|
AU2013359158B2
(en)
|
2012-12-13 |
2018-08-02 |
Allergan, Inc. |
Device and method for making a variable surface breast implant
|
|
US10092392B2
(en)
|
2014-05-16 |
2018-10-09 |
Allergan, Inc. |
Textured breast implant and methods of making same
|
|
KR102600541B1
(ko)
*
|
2016-01-20 |
2023-11-08 |
테라비다, 인코포레이티드 |
다한증을 치료하기 위한 방법 및 조성물
|
|
MX2020010673A
(es)
*
|
2018-04-16 |
2020-10-28 |
Bristol Myers Squibb Co |
Formulaciones de apixaban.
|
|
CN114767636B
(zh)
*
|
2022-04-11 |
2023-11-07 |
苏州中化药品工业有限公司 |
伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊
|